Navigation Links
FDA Grants Astellas Qualified Infectious Disease Product Designation for Isavuconazole for the Treatment of Invasive Aspergillosis
Date:12/3/2013

aspergillosis is caused by Aspergillus molds and typically affects patients with an impaired or weakened immune system. It is estimated to occur in five to 13 percent of recipients of bone marrow transplants often associated with leukemia, five to 25 percent of patients who have received heart or lung transplants, and 10 to 20 percent of patients who are receiving intensive chemotherapy for leukemia.[3] Mortality rates for transplant patients with invasive aspergillosis have been reported to be between 34 and 58 percent.[4] Zygomycosis is an important emerging fungal infection, associated with high morbidity and mortality. Mortality rates have been reported to be as high as 80 percent in infected transplant patients.[5]

About isavuconazole
Isavuconazole (drug substance: isavuconazonium sulfate) is an investigational once daily intravenous and oral broad-spectrum antifungal for the potential treatment of severe invasive and life-threatening fungal infections. It is currently in phase 3 of clinical development. Isavuconazole demonstrated in-vitro and in-vivo coverage of a broad range of yeasts (such as Candida species) and molds (such as Aspergillus species) as well as activity in in-vitro studies and animal models against emerging and often fatal molds including those that cause zygomycosis. Isavuconazole received U.S. FDA fast-track status and U.S. orphan drug designation for invasive aspergillosis and zygomycosis. Isavuconazole is being co-developed with Basilea Pharmaceutica Ltd.

About the isavuconazole phase 3 program
The phase 3 program with isavuconazole includes three studies, SECURE, VITAL and ACTIVE. Recently, positive topline results were reported from the SECURE study, a global randomized, double-blind phase 3 study, designed to evaluate the safety and efficacy of once-daily isavuconazole versus twice-daily voriconazole in the primary treatment of invasive fungal disease caused by Aspergillus species or certain other filamentous fungi
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. RadSite Grants Accreditation to First Wave of MIPPA Program Applicants
2. NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to Regain Compliance with Bid Price Requirement
3. U.S. FDA Grants Orphan Drug Designation for KaloBios KB001-A in Treatment of Cystic Fibrosis Patients
4. FDA Grants 510(k) Clearance for Innovative Fuse Gastroscope from EndoChoice
5. Philanthropic Grants, Product Launches, Promising Partnerships, and Customer Satisfaction Rankings - Research Report on CVS Caremark, Walgreens, McKesson, AmerisourceBergen, and Cardinal Health
6. Life Technologies Awards Digital PCR Innovation Grants to Five Research Labs
7. FDA Grants Lillys Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
8. FDA Grants Orphan Drug Designation to Omeros OMS824 for Huntingtons Disease
9. European Union Grants a Good Manufacturing Practice Certificate to Nelson Laboratories
10. The Kenneth Rainin Foundation Continues its Commitment to Ending Inflammatory Bowel Disease, Awarding $1.5 Million in Research Grants
11. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 A six-hour certification program ... being presented at the Cannabis World Congress & Business ... New York, NY .  Taking place on Wednesday, June ... day of education at the leading event on the East ... Led by Clover Leaf University, the first cannabis university ...
(Date:5/29/2015)... , May 29, 2015  Dr. Yair Walzer ... to resolve vaginal health issues often caused by menopause. The ... requires no anesthesia, received FDA clearance in 2014. Dr. Walzer ... to offer the special fractional CO 2 ... breast cancer survivors. In 2010 there were ...
(Date:5/29/2015)... 29, 2015  The annual customer satisfaction survey of ... EMR as #1 across all specialties. Every year, ... conducts a poll of EHR users and publishes an ... Praxis EMR topped 348 other systems, ... based criteria used by Black Book. In addition to ...
Breaking Medicine Technology:Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2
... Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and ... of a new education campaign designed to help answer ... a reference tool to supplement their discussions about vaccination ... provides consumer-friendly, accurate and science-based information about immunization that ...
... DEERFIELD, Ill., Nov. 17, 2011 Today, Takeda ... (dexlansoprazole) product labeling now includes information from a ... no clinically important effect on exposure to the ... No dose adjustment of clopidogrel is necessary when ...
Cached Medicine Technology:Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization 2Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization 3Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization 4DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 2DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 3DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 4DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 5
(Date:5/29/2015)... To compile the list, the Becker's ... have several awards for clinical and general excellence. The ... out to them in terms of overall excellence, and ... The 50 Great Health Systems to Know 2015 list ... Springs, Fla.) , Advocate Health Care (Downers Grove, Ill.) ...
(Date:5/29/2015)... May 29, 2015 The Healthcare ... graduates of its Advanced Training Program (ATP) in ... fill roles in their health care organization ranging ... and methodology of continuous quality improvement in the ... to Dr. Brent James’ internationally recognized Advanced Training ...
(Date:5/29/2015)... New York (PRWEB) May 29, 2015 ... of patented products, announces that it has signed a ... a technology patent that aims to let people learn ... experts in real time. , "This is an exciting ... Room " said Scott J. Cooper, CEO and Creative ...
(Date:5/29/2015)... Inspire Nexus, a new social network officially launching ... many life coaches have asked, "How do I find ... to become a credentialed Coach?" , Many Life and ... long. Inspire Nexus, a social network for Coaches provides ... have experience coaching a certain number of hours, qualify ...
(Date:5/29/2015)... May 29, 2015 Mediaplanet has joined ... educate readers on the importance of proper sun protection. ... USA Today, with a circulation of approximately 250,000 copies ... component is distributed nationally, through a vast social media ... and partner outlets. To explore the digital version of ...
Breaking Medicine News(10 mins):Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 3Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5
... of long-term use still outweigh possible benefits , SUNDAY, ... seemed like a wonderful means to help women age ... as their bodies began to produce decreased amounts of ... heart disease, osteoporosis and cancer. , But those beliefs ...
... the annual meeting of the American Sociological Association. Below are ... COUNTRY Gay depictions in the media have "exploded" in ... youth still find it difficult to find people like them on ... to help them come to terms with their sexual identity and ...
... undergoes surgery, follow these helpful tips , SATURDAY, Aug. 8 ... undergoing surgery, it helps if parents and children are well-prepared, ... can be a source of stress for a person of ... whole new layer of sensitivity is added," ASA President Dr. ...
... health-care system perspective, it may be more efficient to use ... have a wild-type KRAS gene, according to a study published ... Cancer Institute . Earlier, patients whose tumors harbored wild-type ... treated with cetuximab in a randomized trial by the National ...
... , , Provides Protection for People with ... WASHINGTON, Aug. 7 The Lupus Foundation of America (LFA) President ... regarding S.1630 "The Affordable Access to Prescription Medications Act of ... (Jay) D. Rockefeller IV (D-WV). , , ...
... , , MORRISTOWN, N.J., ... a leading specialty pharmaceutical company, announced today that one lot of ... is being voluntarily recalled from wholesalers and pharmacies. The recalled ... 2011 and were manufactured by Watson Laboratories, Inc. and distributed by ...
Cached Medicine News:Health News:In U.S., No Comeback Seen for Hormone Therapy 2Health News:In U.S., No Comeback Seen for Hormone Therapy 3Health News:Indiana University research at the American Sociological Association annual meeting 2Health News:Indiana University research at the American Sociological Association annual meeting 3Health News:Indiana University research at the American Sociological Association annual meeting 4Health News:Good Planning Paves Way for Kid's Operation 2Health News:Cost-effectiveness of cetuximab in metastatic colorectal cancer 2Health News:The Lupus Foundation of America Applauds New Legislation that Caps Out-of-Pocket Drug Costs 2Health News:Watson Announces Limited Recall Of Fentanyl Transdermal System 2Health News:Watson Announces Limited Recall Of Fentanyl Transdermal System 3
... assay is an immunometric ('sandwich') EIA ... in human serum or plasma. LH ... 2 monoclonal anti-LH antibodies directed at ... to magnetic particles and the other ...
... Luteinizing hormone (LH) is a glycoprotein ... the FSH, hCG and TSH, the intact ... alpha- and beta-subunits. These glycoproteins all have ... unique beta-subunit. Both LH and FSH production ...
... StreamLAB combines consolidated ... Systems with pre- and ... an innovative laboratory automation ... needs of today's laboratories, ...
... simplifies and enhances critical care ... features such as its self-contained ... options, the GEM Premier 3000 ... (iQM), an internal, automated program ...
Medicine Products: